These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific homozygous mutation in CHMP2B. Zhang Y; Schmid B; Nielsen TT; Nielsen JE; Clausen C; Hyttel P; Holst B; Freude KK Stem Cell Res; 2016 Jul; 17(1):151-153. PubMed ID: 27558614 [TBL] [Abstract][Full Text] [Related]
6. Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific heterozygous mutation in CHMP2B. Zhang Y; Schmid B; Nielsen TT; Nielsen JE; Clausen C; Hyttel P; Holst B; Freude KK Stem Cell Res; 2016 Jul; 17(1):148-150. PubMed ID: 27558613 [TBL] [Abstract][Full Text] [Related]
7. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology. Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247 [TBL] [Abstract][Full Text] [Related]
8. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III. Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479 [TBL] [Abstract][Full Text] [Related]
9. Astrocytic reactivity triggered by defective autophagy and metabolic failure causes neurotoxicity in frontotemporal dementia type 3. Chandrasekaran A; Dittlau KS; Corsi GI; Haukedal H; Doncheva NT; Ramakrishna S; Ambardar S; Salcedo C; Schmidt SI; Zhang Y; Cirera S; Pihl M; Schmid B; Nielsen TT; Nielsen JE; Kolko M; Kobolák J; Dinnyés A; Hyttel P; Palakodeti D; Gorodkin J; Muddashetty RS; Meyer M; Aldana BI; Freude KK Stem Cell Reports; 2021 Nov; 16(11):2736-2751. PubMed ID: 34678206 [TBL] [Abstract][Full Text] [Related]
10. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation. Clayton EL; Mancuso R; Nielsen TT; Mizielinska S; Holmes H; Powell N; Norona F; Larsen JO; Milioto C; Wilson KM; Lythgoe MF; Ourselin S; Nielsen JE; Johannsen P; Holm I; Collinge J; ; Oliver PL; Gomez-Nicola D; Isaacs AM Hum Mol Genet; 2017 Mar; 26(5):873-887. PubMed ID: 28093491 [TBL] [Abstract][Full Text] [Related]